MMS22L and breast carcinoma: Previous studies have speculated that MMS22L mutations caused genomic instability and promoted certain types of ovarian and breast cancer (Piwko et al., 2016); however, our data suggested that patients with MMS22L mutations had a better prognosis than patients with wild-type MMS22L in UCEC.